PARK7 DJ-1 protects against degeneration of nigral dopaminergic neurons in Parkinson’s disease rat model
暂无分享,去创建一个
Kazuyuki Takata | Shun Shimohama | Takashi Yanagida | Tomohiro Agatsuma | Hiroyoshi Ariga | K. Yoshimoto | K. Takata | Y. Kitamura | D. Yanagisawa | D. Tsuchiya | T. Taniguchi | S. Shimohama | T. Taira | H. Ariga | M. Inden | Y. Kiso | K. Nishimura | Yoshiaki Kiso | Daijiro Yanagisawa | Yoshihisa Kitamura | Kaneyasu Nishimura | Takahiro Taira | Takashi Taniguchi | Masatoshi Inden | Kanji Yoshimoto | Daiju Tsuchiya | Shizuyo Koide-Yoshida | Sanae M.M. Iguchi-Ariga | T. Yanagida | Tomohiro Agatsuma | Shizuyo Koide-Yoshida | Kaneyasu Nishimura | Daijiro Yanagisawa
[1] T. Taira,et al. DJ-1, a novel oncogene which transforms mouse NIH3T3 cells in cooperation with ras. , 1997, Biochemical and biophysical research communications.
[2] Xin Zhao,et al. Interaction of DJ-1 with Daxx inhibits apoptosis signal-regulating kinase 1 activity and cell death. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[3] Patrizia Rizzu,et al. Mutations in the DJ-1 Gene Associated with Autosomal Recessive Early-Onset Parkinsonism , 2002, Science.
[4] J. Noth,et al. DJ-1 (PARK7) mutations are less frequent than Parkin (PARK2) mutations in early-onset Parkinson disease , 2004, Neurology.
[5] T. Niki,et al. DJ-1 interacts with HIPK1 and affects H2O2-induced cell death , 2006, Free radical research.
[6] Steven P Gygi,et al. The Parkinson's disease-associated DJ-1 protein is a transcriptional co-activator that protects against neuronal apoptosis. , 2005, Human molecular genetics.
[7] Jean-Charles Sanchez,et al. PARK7 and nucleoside diphosphate kinase A as plasma markers for the early diagnosis of stroke. , 2005, Clinical chemistry.
[8] Mark A. Wilson,et al. The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[9] P. Calabresi,et al. Nigrostriatal Dopaminergic Deficits and Hypokinesia Caused by Inactivation of the Familial Parkinsonism-Linked Gene DJ-1 , 2005, Neuron.
[10] Robert L. Nussbaum,et al. Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease , 1997 .
[11] Y. Kitamura,et al. Disease model: Parkinson's disease. , 2003, Trends in molecular medicine.
[12] G. Petsko,et al. The 1.1-Å resolution crystal structure of DJ-1, the protein mutated in autosomal recessive early onset Parkinson's disease , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[13] E. Masliah,et al. Increased level of DJ-1 in the cerebrospinal fluids of sporadic Parkinson's disease. , 2006, Biochemical and biophysical research communications.
[14] A. Abeliovich,et al. DJ-1 Is a Redox-Dependent Molecular Chaperone That Inhibits α-Synuclein Aggregate Formation , 2004, PLoS biology.
[15] Georg Auburger,et al. The ubiquitin pathway in Parkinson's disease , 1998, Nature.
[16] Thomas Floss,et al. Sensitivity to Oxidative Stress in DJ-1-Deficient Dopamine Neurons: An ES- Derived Cell Model of Primary Parkinsonism , 2004, PLoS biology.
[17] T. Niki,et al. DJBP: a novel DJ-1-binding protein, negatively regulates the androgen receptor by recruiting histone deacetylase complex, and DJ-1 antagonizes this inhibition by abrogation of this complex. , 2003, Molecular cancer research : MCR.
[18] C. Haass,et al. Differential Effects of Parkinson's Disease-associated Mutations on Stability and Folding of DJ-1* , 2004, Journal of Biological Chemistry.
[19] K. Yoshimoto,et al. Possibility of 5-HT3 receptor involvement in alcohol dependence: a microdialysis study of nucleus accumbens dopamine and serotonin release in rats with chronic alcohol consumption. , 1996, Alcoholism, clinical and experimental research.
[20] S. Przedborski,et al. Inactivation of tyrosine hydroxylase by nitration following exposure to peroxynitrite and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[21] Mark A. Wilson,et al. The oxidation state of DJ-1 regulates its chaperone activity toward α-synuclein , 2006 .
[22] P. Seth,et al. Olfactory ensheathing cell transplantation restores functional deficits in rat model of Parkinson's disease: a cotransplantation approach with fetal ventral mesencephalic cells , 2004, Neurobiology of Disease.
[23] P. Bramanti,et al. Prolonged blockade of NMDA or mGluR5 glutamate receptors reduces nigrostriatal degeneration while inducing selective metabolic changes in the basal ganglia circuitry in a rodent model of Parkinson's disease , 2006, Neurobiology of Disease.
[24] Hiroyoshi Ariga,et al. DJ-1 Positively Regulates the Androgen Receptor by Impairing the Binding of PIASxα to the Receptor* , 2001, The Journal of Biological Chemistry.
[25] Li Zhang,et al. A missense mutation (L166P) in DJ‐1, linked to familial Parkinson's disease, confers reduced protein stability and impairs homo‐oligomerization , 2003, Journal of neurochemistry.
[26] K. Takata,et al. Proteasome inhibitors protect against degeneration of nigral dopaminergic neurons in hemiparkinsonian rats. , 2005, Journal of pharmacological sciences.
[27] Tiffany Mathews,et al. Age-dependent Motor Deficits and Dopaminergic Dysfunction in DJ-1 Null Mice* , 2005, Journal of Biological Chemistry.
[28] Keith D Wilkinson,et al. Familial Parkinson's Disease-associated L166P Mutation Disrupts DJ-1 Protein Folding and Function* , 2004, Journal of Biological Chemistry.
[29] P. Lockhart,et al. Quantitative proteomic analysis of mitochondrial proteins: relevance to Lewy body formation and Parkinson's disease. , 2005, Brain research. Molecular brain research.
[30] P. Ragonese,et al. DJ‐1 mutations and parkinsonism‐dementia‐amyotrophic lateral sclerosis complex , 2005, Annals of neurology.
[31] Hiroyoshi Ariga,et al. Stimulation of transforming activity of DJ-1 by Abstrakt, a DJ-1-binding protein. , 2005, International journal of oncology.
[32] David W. Miller,et al. Effects of DJ-1 mutations and polymorphisms on protein stability and subcellular localization. , 2005, Brain research. Molecular brain research.
[33] Y. Kitamura,et al. Mechanism of resistance to NO‐induced neurotoxicity in cultured rat dopaminergic neurons , 1996, Journal of neuroscience research.
[34] Jos Prickaerts,et al. Modeling Parkinson's Disease in Rats: An Evaluation of 6-OHDA Lesions of the Nigrostriatal Pathway , 2002, Experimental Neurology.
[35] David S. Park,et al. Hypersensitivity of DJ-1-deficient mice to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrindine (MPTP) and oxidative stress. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[36] T. Niki,et al. DJ-1 restores p53 transcription activity inhibited by Topors/p53BP3. , 2005, International journal of oncology.
[37] G. Paxinos,et al. The Rat Brain in Stereotaxic Coordinates , 1983 .
[38] P. Heutink,et al. The DJ-1L166P mutant protein associated with early onset Parkinson's disease is unstable and forms higher-order protein complexes. , 2003, Human molecular genetics.
[39] T. Oury,et al. Manganese Superoxide Dismutase Protects against 6-Hydroxydopamine Injury in Mouse Brains* , 2005, Journal of Biological Chemistry.
[40] T. Niki,et al. The Crystal Structure of DJ-1, a Protein Related to Male Fertility and Parkinson's Disease* , 2003, Journal of Biological Chemistry.
[41] T. Taira,et al. Induction of reactive oxygen species by bisphenol A and abrogation of bisphenol A-induced cell injury by DJ-1. , 2005, Toxicological sciences : an official journal of the Society of Toxicology.
[42] P. Jenner,et al. Oxidative stress in Parkinson's disease , 2003, Annals of neurology.
[43] T. Iwatsubo,et al. Lentiviral vector delivery of parkin prevents dopaminergic degeneration in an alpha-synuclein rat model of Parkinson's disease. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[44] Y. Kitamura,et al. Protective effects of the antiparkinsonian drugs talipexole and pramipexole against 1-methyl-4-phenylpyridinium-induced apoptotic death in human neuroblastoma SH-SY5Y cells. , 1998, Molecular pharmacology.
[45] H. Ariga,et al. Down regulation of DJ-1 enhances cell death by oxidative stress, ER stress, and proteasome inhibition. , 2003, Biochemical and biophysical research communications.
[46] T. Niki,et al. DJ‐1 has a role in antioxidative stress to prevent cell death , 2004, EMBO reports.
[47] N. Quinn,et al. The role of pathogenic DJ‐1 mutations in Parkinson's disease , 2003, Annals of neurology.
[48] K. Takata,et al. High mobility group box protein‐1 inhibits microglial Aβ clearance and enhances Aβ neurotoxicity , 2004 .
[49] Hiroyoshi Ariga,et al. Association of DJ-1 with chaperones and enhanced association and colocalization with mitochondrial Hsp70 by oxidative stress , 2005, Free radical research.
[50] H. Ariga,et al. Expression and cellular localization of contraception-associated protein. , 2000, Journal of andrology.
[51] Andrew Lees,et al. Cloning of the Gene Containing Mutations that Cause PARK8-Linked Parkinson's Disease , 2004, Neuron.
[52] T. Niki,et al. Proper SUMO-1 conjugation is essential to DJ-1 to exert its full activities , 2006, Cell Death and Differentiation.
[53] Liang Tong,et al. Crystal Structure of Human DJ-1, a Protein Associated with Early Onset Parkinson's Disease* , 2003, Journal of Biological Chemistry.
[54] R. Nussbaum,et al. Hereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1 , 2004, Science.
[55] K. Takata,et al. Serofendic acid prevents 6‐hydroxydopamine‐induced nigral neurodegeneration and drug‐induced rotational asymmetry in hemi‐parkinsonian rats , 2005, Journal of neurochemistry.
[56] T. Niki,et al. Reduced anti-oxidative stress activities of DJ-1 mutants found in Parkinson's disease patients. , 2004, Biochemical and biophysical research communications.
[57] Thomas Meitinger,et al. Mutations in LRRK2 Cause Autosomal-Dominant Parkinsonism with Pleomorphic Pathology , 2004, Neuron.
[58] Rina Bandopadhyay,et al. The expression of DJ-1 (PARK7) in normal human CNS and idiopathic Parkinson's disease. , 2004, Brain : a journal of neurology.
[59] L. Paraoan,et al. Cystatin C prevents degeneration of rat nigral dopaminergic neurons: in vitro and in vivo studies , 2005, Neurobiology of Disease.
[60] David W. Miller,et al. L166P Mutant DJ-1, Causative for Recessive Parkinson's Disease, Is Degraded through the Ubiquitin-Proteasome System* , 2003, Journal of Biological Chemistry.
[61] Vincenzo Bonifati,et al. Early‐onset Parkinson's disease caused by a compound heterozygous DJ‐1 mutation , 2003, Annals of neurology.
[62] H. Lipp,et al. Hsp70 gene transfer by adeno-associated virus inhibits MPTP-induced nigrostriatal degeneration in the mouse model of Parkinson disease. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.
[63] Reidun Torp,et al. Mitochondrial localization of the Parkinson's disease related protein DJ-1: implications for pathogenesis. , 2005, Human molecular genetics.
[64] M. Cameron Sullards,et al. Oxidative Damage of DJ-1 Is Linked to Sporadic Parkinson and Alzheimer Diseases* , 2006, Journal of Biological Chemistry.
[65] M. Mintz,et al. Behavioral and Anatomical Effects of Long-Term l-Dihydroxyphenylalanine (L-DOPA) Administration in Rats with Unilateral Lesions of the Nigrostriatal System , 2002, Experimental Neurology.
[66] Tomoya Kinumi,et al. Cysteine-106 of DJ-1 is the most sensitive cysteine residue to hydrogen peroxide-mediated oxidation in vivo in human umbilical vein endothelial cells. , 2004, Biochemical and biophysical research communications.
[67] David E. Misek,et al. Proteomics-based identification of RS/DJ-1 as a novel circulating tumor antigen in breast cancer. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.
[68] S. Minoshima,et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism , 1998, Nature.